Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer
Travecta Therapeutics, Pte Ltd. incorporated in Singapore on 7th April 2017, a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced the appointment of Charles S. Ryan, JD, PhD as President and Chief Executive Officer. Dr. Ryan recently served as Chief Executive Officer and Director of Neurotrope, Inc. In his new role, Dr. Charles Ryan will work closely with the scientific team to develop novel therap
Source: yahoo.com